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Introduction
Critical weight loss (CWL) is deﬁned as an unintentional
weight loss of  5% at 1 month or  10% at 6 months from
the start of treatment.1 Due to the location of the tumor,
there is difﬁculty in mastication, which leads to further
weight loss. Critical weight loss is seen in up to 55% of
head and neck cancer patients;1 it leads to deterioration of
the immune function and reduced tolerance to treatment
(surgery  radiochemotherapy) as well as increased com-
plication rates.1 Finally, CWL also impairs the functional
status and worsens the quality of life.1
During the treatment, the patients develop acute toxicity,
mostly due to radiotherapy.2 The most common treatment-
related toxicity is mucositis that leads to dysphagia and
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Abstract Introduction Critical weight loss is deﬁned as an unintentional weight loss of  5% at
1 month or  10% at 6months from the start of treatment. Critical weight loss leads to
deterioration of the immune function and reduced tolerance to treatment (surgery
 radiochemotherapy) as well as increased complication rates.
Objective Critical weight loss, deﬁned as a weight loss of  5% after 1 month
or  10% after 6 months from the start of treatment, is not uncommon in head and
neck cancer patients. We aimed to assess the factors associated with critical weight loss
during the treatment of oral cavity squamous cell carcinoma patients.
Methods A retrospective cohort study was performed at the Aga Khan University
Hospital, in Karachi, Pakistan, on 125 patients. Patients receiving adjuvant therapy
were considered exposed, and the outcome was critical weight loss.
Results The mean age of presentation was 46.9  12.8 years in patients undergoing
surgery and adjuvant therapy, with 119 (79.3%) of them being male and 31 (20.7%)
female. One hundred and twelve patients (81.3%) developed critical weight loss at 6
months from the start of treatment, and the only signiﬁcant variable associated with
critical weight loss was the stage of the disease (p ¼ 0.03).
Conclusion A large proportion of patients with oral cancer developed critical weight
loss requiring a need for intervention. The overall stage of the disease is a signiﬁcant
predictor of critical weight loss in patients undergoing treatment.
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further aggravates the problemof weight loss.2Malnutrition,
that ismost commonly assessed byweight loss, is seen in 41–
88% of patients receiving radiotherapy.2 The toxicity of
radiotherapy and reduction in weight continue weeks after
completion of radiotherapy.2 Critical weight loss has also
shown to be an independent risk factor for disease-free
survival in patients undergoing radiotherapy.
Therefore, it is of utmost importance to determine the
prevalence and factors associated with CWL in patients
receiving treatment (surgery  adjuvant therapy) for oral
cavity squamous cell carcinoma in our population based in a
developing country, which was the aim of this study.
Material and Methods
A retrospective cohort study was conducted from January to
December 2014. Institutional ethical review committee
exemption was obtained before the beginning of the study.
The study sitewas a tertiary care hospital where the patients
were diagnosed and treated. The data was collected via non-
purposive consecutive sampling. All patients receiving treat-
ment for oral cavity squamous cell carcinoma from January
to December 2014 were included in the study
Inclusion criteria were patients  18 years with con-
ﬁrmed diagnosis of squamous cell carcinoma of oral cavity
treated at the tertiary care hospital. Exclusion criteria were
patients with histological ﬁndings other than squamous cell
carcinoma, distant metastasis before the commencement of
treatment and patients treated primarily outside Aga Khan
University Hospital. Patients with missing data, those who
did not complete their treatment and those whowere lost to
follow-up were excluded from the study. Patients with pT4b
(advanced stage) tumors were also excluded as these
patients are referred for palliative treatment and are not
admitted under our care.
The weight and height were assessed and documented at
the time of ﬁrst reporting to the outpatient clinic and the
weight was assessed at the ﬁrst postoperative visit and at
every follow-up visit by the clinic staff using a standardized
weighing machine. In this study, CWL was deﬁned as weight
loss of more than 10% at 6 months from the commencement
of treatment (surgery) At this time, the patients with
advanced-stage disease (pT3-T4) had completed their adju-
vant therapy and were on a regular 4 weekly follow-up visit
schedule. All the patients had a dietitian’s input at the time of
discharge. The patients were stratiﬁed into oral intake and
tube feeding. Patients either remained on oral diet intake, if
the disease is of early stage and not affecting swallowing
after surgery, or tube feeding was instigated if the tumor was
of late stage or if the patient was expected to require
adjuvant treatment postoperatively, which impedes oral
intake. Tube feeding was further stratiﬁed into none, naso-
gastric tube, gastrostomy and per-endoscopic gastrostomy.
The patients were divided into two groups, surgery alone
(unexposed) and surgery þ adjuvant therapy (exposed). The
chemotherapeutic agent used as an adjunct regimen for our
patients was cisplatin and 5-ﬂuorouracil. The outcome was
dichotomous (yes/no) CWL. The univariate analysis was
conducted ﬁrst (p ¼ 0.25). Each signiﬁcant variable was
then added for model building based on the likelihood score.
Multiple logistic regressionwas run on the ﬁnal model using
the software STATA version 12 (StataCorp LLC, College Sta-
tion, TX, USA). The only statistically signiﬁcant variable in our
ﬁnal model was the overall stage of the disease.
Results
A total of 150 patients were included in the study, who had
undergone treatment for oral cavity squamous cell carci-
noma in the year of 2014 at our institute. The data was
stratiﬁed on the primary exposure variable, which was
adjuvant therapy (radiotherapy/chemotherapy/both). Vari-
ables having less cell count in the sub-categories (< 5), such
as site of tumor (tongue/buccal mucosa/alveolus), patholo-
gical T-stage (early ¼ pT1 & 2, late ¼ pT3 & 4), overall stage
(early ¼ 1 & 2, late ¼ 3 & 4) and co-morbidities (yes/no),
were merged.
There was a total of 111 patients who underwent surgery
and adjuvant therapy, and 39 patients who had surgery
alone. The mean age of the patients undergoing surgery
along with adjuvant therapy was 46.9  12.77 years. The
majority of the patients were males 89 (80.2%), and the
remaining 22 (19.8%) were females (►Table 1).
The majority of the patients—122 (81.3%)—developed
CWL, that is, weight loss of more than 5% at 1 month or
more than 10% of the body weight at 6 months from the
commencement of treatment (surgery). Of all the variables
under consideration, the signiﬁcant variables at univariate
analysis (p ¼ 0.25) were overall stage, mode of nutrition
(oral/stomach tubes), type of enteral nutrition (PEG/gastro-
stomy/nasogastric tube), pathological T-stage, adjuvant
therapy and comorbidities (►Table 2). The multicollinearity
(cutoff 0.8) amongst the variables was assessed using ETA.
Cramer and Pearson correlation and was not present. The
multivariable analysis revealed the overall stage (p ¼ 0.03)
to be signiﬁcantly associatedwith CWL, keeping the primary
exposure variable (adjuvant therapy) in the model
(►Table 3). Goodness-of-ﬁt of the ﬁnal model was assessed
using Pearson Goodness-of-ﬁt, and the ﬁnal model ﬁt well.
(Pearson chi 83.52, p ¼ 0.99). The interaction was assessed
between biologically plausible variables, but no interaction
was seen. The receiver operating characteristic (ROC) curve
was plotted after running binary logistic regression on the
ﬁnal model (Area under curve ¼ 0.7825) (►Fig. 1).
In conclusion, the risk of developing CWL is 1.73 times
higher in patients with advanced stage disease (stages III &
IV) when compared with patients in the early stages of the
disease (stages I & II) keeping the primary exposure in the
model (adjuvant treatment).
Discussion
Cancer anywhere in the body causes cachexia. It is thought
that the systemic effects of carcinoma lead to changes in
appetite and taste;1,3 these changes coupled with the loca-
tion of tumor in the oral cavity causing mechanical
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obstruction—that is, dysphagia and odynophagia—are
thought to cause a further reduction in weight over the
course of time.1 The aim of the present study was to assess
weight loss in patients over the course of treatment (surgery
 adjuvant therapy) at a tertiary care setting in a developing
country.
Criticalweight loss prior to the start of treatment has been
reported in 31–57% of patients.1 This assessment of weight
Table 1 Patient demographics and tumor-related variables
Variable Unexposed
(Surgery alone)
n (%)
Exposed
(Surgery þ adjuvant therapy)
n (%)
Age Mean (SD) 51.48 (10.55) 46.91 (12.76)
Gender Males 30 (76.9) 89 (80.2)
Females 9 (23.1) 22 (19.8)
Comorbidities No 30 (76.9) 80 (72.1)
Yes 9 (23.1) 31 (27.9)
Site Tongue 14 (35.9) 24 (21.6)
Buccal mucosa 22 (56.4) 66 (59.5)
Alveolus 3 (7.7) 21 (18.9)
pT Early (I & II) 25 (64.1) 46 (41.4)
Late (III & IV) 14 (34.9) 65 (58.6)
Overall stage Early (I & II) 21(53.8) 20 (18)
Late (III & IV) 18 (46.15) 91 (82)
Type of neck dissection None 3 (7.7) 0 (0)
Supraomohyoid ND 7 (17.9) 11 (9.9)
Selective ND 7 (17.9) 21 (18.9)
Modiﬁed radical ND 13 (33.3) 57 (51.3)
Radical ND 9 (23) 22 (19.8)
Bilateral/unilateral neck dissection No 28 (71.8) 68 (61.3)
Yes 11 (28.2) 43 (38.7)
pN stage N0 26 (66.7) 0 (0)
N1 2 (5.1) 10 (9)
N2a 0 (0) 36 (32.4)
N2b 8 (20.5) 22 (19.8)
N2c 3 (15.4) 43 (38.7)
Grade of tumor Well differentiated 17 (43.6) 26 (23.4)
Moderately differentiated 18 (46.1) 69 (62.2)
Poorly differentiated 4(10.3) 16 (14.4)
Perineural invasion No 35 (89.4) 90 (81.1)
Yes 4 (10.3) 21 (18.9)
Extra capsular spread No 27 (69.2) 84 (75.7)
Yes 12 (30.8) 27 (24.3)
Mode of nutrition Oral 26 (66.7) 95 (85.6)
Tube feeding 13 (33.3) 16 (14.4)
Type of tube feeding None 12 (30.7) 15 (13.5)
Nasogastric tube 2 (5.1) 5 (4.5)
Gastrostomy 20 (51.2) 60 (54)
Per-endoscopic gastrostomy 5 (12.8) 31 (27.93)
Abbreviations: ND, neck dissection; pN, pathological assessment of the regional lymph nodes; pT, primary tumor; SD, standard deviation.
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loss of  5% in 1 month or  10% in 6 months before the
start of treatment could be subjective and may be over-
estimated owing to the recall bias. We studied CWL over the
course of treatment at our center, and the patients’ weight
was recorded at every follow-up visit starting from the time
when the diagnosis wasmade. Our results show that 81.3% of
the patients developed CWL over the course of the treat-
ment, which is a signiﬁcant number. Where other studies
aimed to study CWL in all patients presenting with head and
neck cancer,1,2,4 we focused our study on patients with oral
cavity carcinoma due to its high prevalence in our region,5
which might estimate results close to parameter. Also, pre-
vious studies have shown a greater weight loss in patients
with oral cavity carcinoma when compared with other sites
in the head and neck area, making it a high-risk category.1
Studies have shown various factors to be signiﬁcantly
associated with weight loss at and around the time of radio-
therapy, which is known to cause toxicity.6 Tumor site (oral
cavity) is awell-recognized factor that leads toweight loss.4 In
our study, we subcategorized the tumor location within the
oral cavity and assessed its signiﬁcance with CWL. The tumor
site within the oral cavity, such as tongue and buccal mucosa,
did not show signiﬁcant association with CWL (p ¼ 0.33) in
the univariate or multivariable analyses.
Enteral feeding via feeding tubes is still a topic of debate,
especially for patients in the early stages of the disease
Table 2 Univariate analysis signiﬁcance (p-value ¼ 0.25)
Serial # Variable p-value LR Unadjusted
HR (RR)
Z-test
1 Age 0.61 0.27 0.99 0.51
2 Gender 0.96 0.00 0.99 0.05
3 Comorbidities 0.13 2.24 1.34 1.52
4 Site 0.33 2.24 1.37
1.45
1.34
1.26
5 Neck dissection type 0.79 1.71 2.16 0.75
6 Bilateral/unilateral ND 0.44 0.58 1.15 0.77
7 Stage 0.008 6.92 1.81 2.47
8 pT 0.01 6.32 1.59 2.47
9 pN 0.81 1.57 1.24 0.86
10 Grade 0.91 0.2 1.06
0.95
0.29
-0.17
11 Perineural spread 0.56 0.33 0.87 0.57
12 Extra capsular spread 0.50 0.45 1.14 0.68
13 Mode of nutrition 0.009 6.78 0.50 2.38
14 Source of enteral feeding 0.09 6.39 1.93 1.31
15 Adjuvant treatment 0.15 2.02 1.36 1.38
Abbreviations: HR, hazard ratio; LR, chi2 Likelihood; ND, neck dissection; pN, pathological assessment of the regional lymph nodes; pT, primary
tumor; RR, relative risk.
Table 3 Multivariable analysis signiﬁcance (p-value ¼ 0.05) using cox proportional algorithm
Serial # Variable LR p-value RR Z-test p-value
1 Adjuvant therapy (primary exposure) 7.23 0.02 1.73 2.17 0.03
2 Stage 7.23 0.02 1.14 0.56 0.58
Abbreviations: LR, chi2 Likelihood; RR, relative risk.
Fig. 1 Receiver Operating Characteristic (ROC) curve of the ﬁnal
model.
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who undergo postoperative radiotherapy.4 However, recent
studies have shown that tube feeding is not indicated for
all patients undergoing radiotherapy; rather, a careful
decision should be made, especially for patients in the early
stages of the disease.4 This could be because early-stage
patients undergo limited resection of the tumor followed by
radiotherapy that may be well tolerated. In our study, the
mode of nutrition (oral/feeding tubes) was statistically
signiﬁcant in univariate analysis (p ¼ 0.009), and the type
of feeding tube used (PEG/gastrostomy/NGT) was also sig-
niﬁcant (p ¼ 0.09) but only in the multivariable analysis.
However, none of these factors ﬁt into the ﬁnal model to
predict CWL.
The stages of cancer are generally divided into early
(stages I & II) and late (stages III & IV), and a comparison
drawn between them shows that patients with advanced-
stage disease are more likely to develop weight loss and also
to receive enteral nutrition.We categorized our stage accord-
ingly and the stage of disease was signiﬁcant (p ¼ 0.03) on
multivariable analysis in the ﬁnal model. The pathological
T-stage was signiﬁcant (p ¼ 0.01) on the univariate analysis
but was insigniﬁcant on the multivariable analysis. Critical
weight loss in advanced-stage disease can be explained by
the fact that patients undergo an extensive surgical resection
involving the bone and, at times, reconstruction, thereby
requiring a longer duration for healing and returning back to
the normal physiology. Patientswith advanced-stage disease
also tend to receive radio and chemotherapy, and each of
these modalities have their toxic effects.
Critical weight loss in our cohort was seen in more than
2/3 of the cases, and it could be attributed to the poor
economic conditions of a developing country, lack of educa-
tion and lack of proper dietary follow-up and input. We
acknowledge that our study has limitations, which reside in
its retrospective design. We had to exclude a signiﬁcant
number of cases due to loss to follow-up and missing data.
Although a standardized weighing tool was used to assess
weight at every follow-up visit, there could have been a
slight variability given that three different clinic staff
members had been assessing the weight. Given the limita-
tions, however, our study provides insight into the nutri-
tional status of patients under treatment at a tertiary care
center in our population. Our results could be generalized
given the wide range of socioeconomic classes our hospital
caters to because of availability of welfare funds. Further
prospective studies are needed to establish the diet plan
patients follow during their course of treatment and its
impact on weight loss.
Conclusion
Oral cavity carcinoma patients are at an increased risk of
developing CWL over the course of their treatment. Lack of
resources and poor economic conditions of a developing
country further add to the challenges in maintaining good
physical condition during the course of treatment. The ﬁnal
stages of the disease and adjuvant treatment (radio/che-
motherapy) are factors that predict CWL. Special attention in
terms of dietary input is required for patientswith advanced-
stage disease receiving adjuvant treatment.
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